Synopsys Increases Stock Repurchase Authorization to $500 Million




MOUNTAIN VIEW, Calif., Sept. 9 /PRNewswire-FirstCall/ -- Synopsys, Inc. (NASDAQ: SNPS), a world leader in software and IP for semiconductor design, verification and manufacturing, announced today that its Board of Directors has replenished its stock repurchase authorization. Under the replenished program, the Company may repurchase Synopsys common stock with a market value up to $500 million.


Purchases may be made beginning immediately and ending at such time as the authorized funds are spent or the program is discontinued. The program does not obligate Synopsys to acquire any particular amount of common stock, and the program may be modified or suspended at any time at Synopsys' discretion. The purchases will be funded from available working capital.


About Synopsys

Synopsys, Inc. (NASDAQ: SNPS) is a world leader in electronic design automation (EDA), supplying the global electronics market with the software, intellectual property (IP) and services used in semiconductor design, verification and manufacturing. Synopsys' comprehensive, integrated portfolio of implementation, verification, IP, manufacturing and field-programmable gate array (FPGA) solutions helps address the key challenges designers and manufacturers face today, such as power and yield management, software-to-silicon verification and time-to-results. These technology-leading solutions help give Synopsys customers a competitive edge in bringing the best products to market quickly while reducing costs and schedule risk. Synopsys is headquartered in Mountain View, California, and has more than 65 offices located throughout North America, Europe, Japan, Asia and India. Visit Synopsys online at


Forward-Looking Statements


Certain statements in this press release including, but not limited to, any statements relating to the timing and extent of any stock repurchases are forward-looking statements that are subject to risks and uncertainties that could cause results to be materially different than expectations. Important factors that could cause actual results to differ materially include the fluctuations in the overall stock market and the price of Synopsys stock, the level of employee option grants and exercises and resulting dilution; Synopsys' use of cash for other purposes, conditions of the global economy as well as other factors detailed from time to time in the reports Synopsys files with the Securities and Exchange Commission including, including those described in the "Risk Factors" section of its Quarterly Report on Form 10-Q for the fiscal quarter ended April 30, 2009. These forward-looking statements speak only as of the date hereof, and, except as required by law, Synopsys disclaims any obligation to update these forward-looking statements to reflect future events or circumstances.


Synopsys is a registered trademark of Synopsys, Inc. Any other trademarks mentioned in this release are the property of their respective owners.


    Lisa L. Ewbank
    Synopsys, Inc.

    Sheryl Gulizia
    Synopsys, Inc.






SOURCE Synopsys, Inc.

SOURCE: Synopsys, Inc.

Web site: